Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 100

1.

Cannabis induced dopamine release: an in-vivo SPECT study.

Voruganti LN, Slomka P, Zabel P, Mattar A, Awad AG.

Psychiatry Res. 2001 Oct 1;107(3):173-7.

PMID:
11566433
[PubMed - indexed for MEDLINE]
2.

Single photon emission computerized tomography imaging of amphetamine-induced dopamine release in drug-free schizophrenic subjects.

Laruelle M, Abi-Dargham A, van Dyck CH, Gil R, D'Souza CD, Erdos J, McCance E, Rosenblatt W, Fingado C, Zoghbi SS, Baldwin RM, Seibyl JP, Krystal JH, Charney DS, Innis RB.

Proc Natl Acad Sci U S A. 1996 Aug 20;93(17):9235-40.

PMID:
8799184
[PubMed - indexed for MEDLINE]
Free PMC Article
3.

Associated alterations of striatal dopamine D2/D3 receptor and transporter binding in drug-naive patients with schizophrenia: a dual-isotope SPECT study.

Yang YK, Yu L, Yeh TL, Chiu NT, Chen PS, Lee IH; SPECT study.

Am J Psychiatry. 2004 Aug;161(8):1496-8.

PMID:
15285982
[PubMed - indexed for MEDLINE]
4.

[99mTc]TRODAT-1/[123I]IBZM SPECT studies of the dopaminergic system in Tourette syndrome.

Hwang WJ, Yao WJ, Fu YK, Yang AS.

Psychiatry Res. 2008 Feb 28;162(2):159-66. doi: 10.1016/j.pscychresns.2007.04.006.

PMID:
18248965
[PubMed - indexed for MEDLINE]
5.

Striatal dopamine transporter availability is associated with the productive psychotic state in first episode, drug-naive schizophrenic patients.

Schmitt GJ, Frodl T, Dresel S, la Fougère C, Bottlender R, Koutsouleris N, Hahn K, Möller HJ, Meisenzahl EM.

Eur Arch Psychiatry Clin Neurosci. 2006 Mar;256(2):115-21. Epub 2005 Nov 15.

PMID:
16284713
[PubMed - indexed for MEDLINE]
6.

Association between cognitive performance and striatal dopamine binding is higher in timing and motor tasks in patients with schizophrenia.

Yang YK, Yeh TL, Chiu NT, Lee IH, Chen PS, Lee LC, Jeffries KJ.

Psychiatry Res. 2004 Sep 15;131(3):209-16.

PMID:
15465290
[PubMed - indexed for MEDLINE]
7.

Cannabis and psychosis: an update on course and biological plausible mechanisms.

Linszen D, van Amelsvoort T.

Curr Opin Psychiatry. 2007 Mar;20(2):116-20. Review.

PMID:
17278907
[PubMed - indexed for MEDLINE]
8.

Striatal dopamine D2 receptor density in neuroleptic-naive and in neuroleptic-free schizophrenic patients: an 123I-IBZM-SPECT study.

Lomeña F, Catafau AM, Parellada E, Bernardo M, Font M, Gutiérrez F, Pavía J.

Psychopharmacology (Berl). 2004 Mar;172(2):165-9. Epub 2003 Nov 18.

PMID:
14624330
[PubMed - indexed for MEDLINE]
9.

Striatal amphetamine-induced dopamine release in patients with schizotypal personality disorder studied with single photon emission computed tomography and [123I]iodobenzamide.

Abi-Dargham A, Kegeles LS, Zea-Ponce Y, Mawlawi O, Martinez D, Mitropoulou V, O'Flynn K, Koenigsberg HW, Van Heertum R, Cooper T, Laruelle M, Siever LJ.

Biol Psychiatry. 2004 May 15;55(10):1001-6.

PMID:
15121484
[PubMed - indexed for MEDLINE]
10.

[(123)I]beta-CIT SPECT is a useful method for monitoring dopaminergic degeneration in early stage Parkinson's disease.

Winogrodzka A, Bergmans P, Booij J, van Royen EA, Stoof JC, Wolters EC.

J Neurol Neurosurg Psychiatry. 2003 Mar;74(3):294-8.

PMID:
12588911
[PubMed - indexed for MEDLINE]
Free PMC Article
11.

Correlation between striatal dopamine D2/D3 receptor binding and cardiovascular activity in healthy subjects.

Yeh TL, Yang YK, Chiu NT, Yao WJ, Yeh SJ, Wu JS, Chuang JI, Chang SH.

Am J Hypertens. 2006 Sep;19(9):964-9.

PMID:
16942941
[PubMed - indexed for MEDLINE]
12.

[123I]Iodobenzamide binding to the rat dopamine D2 receptor in competition with haloperidol and endogenous dopamine--an in vivo imaging study with a dedicated small animal SPECT.

Nikolaus S, Larisch R, Wirrwar A, Jamdjeu-Nouné M, Antke C, Beu M, Schramm N, Müller HW.

Eur J Nucl Med Mol Imaging. 2005 Nov;32(11):1305-10. Epub 2005 Jul 8.

PMID:
16003562
[PubMed - indexed for MEDLINE]
13.

Comparison of striatal dopamine D2 receptors in Parkinson's disease and progressive supranuclear palsy patients using [123I] iodobenzofuran single-photon emission computed tomography.

Oyanagi C, Katsumi Y, Hanakawa T, Hayashi T, Thuy Dh, Hashikawa K, Nagahama Y, Fukuyama H, Shibasaki H.

J Neuroimaging. 2002 Oct;12(4):316-24.

PMID:
12380478
[PubMed - indexed for MEDLINE]
14.

Increase of striatal dopamine transmission in first episode drug-naive schizophrenic patients as demonstrated by [(123)I]IBZM SPECT.

Schmitt GJ, Meisenzahl EM, Frodl T, La Fougère C, Hahn K, Möller HJ, Dresel S.

Psychiatry Res. 2009 Sep 30;173(3):183-9. doi: 10.1016/j.pscychresns.2008.11.001. Epub 2009 Aug 15.

PMID:
19683898
[PubMed - indexed for MEDLINE]
15.

Quantitative analysis of striatal dopamine D2 receptors with 123 I-iodolisuride SPECT in degenerative extrapyramidal diseases.

Prunier C, Tranquart F, Cottier JP, Giraudeau B, Chalon S, Guilloteau D, De Toffol B, Chossat F, Autret A, Besnard JC, Baulieu JL.

Nucl Med Commun. 2001 Nov;22(11):1207-14.

PMID:
11606886
[PubMed - indexed for MEDLINE]
16.

Striatal dopamine release after prefrontal repetitive transcranial magnetic stimulation in major depression: preliminary results of a dynamic [123I] IBZM SPECT study.

Pogarell O, Koch W, Pöpperl G, Tatsch K, Jakob F, Zwanzger P, Mulert C, Rupprecht R, Möller HJ, Hegerl U, Padberg F.

J Psychiatr Res. 2006 Jun;40(4):307-14. Epub 2005 Nov 2.

PMID:
16259998
[PubMed - indexed for MEDLINE]
17.

Receptor and transporter imaging studies in schizophrenia, depression, bulimia and Tourette's disorder--implications for psychopharmacology.

Kasper S, Tauscher J, Willeit M, Stamenkovic M, Neumeister A, Küfferle B, Barnas C, Stastny J, Praschak-Rieder N, Pezawas L, de Zwaan M, Quiner S, Pirker W, Asenbaum S, Podreka I, Brücke T.

World J Biol Psychiatry. 2002 Jul;3(3):133-46. Review.

PMID:
12478878
[PubMed - indexed for MEDLINE]
18.

Subjective and behavioural consequences of striatal dopamine depletion in schizophrenia--findings from an in vivo SPECT study.

Voruganti LN, Awad AG.

Schizophr Res. 2006 Dec;88(1-3):179-86. Epub 2006 Sep 1.

PMID:
16949796
[PubMed - indexed for MEDLINE]
19.

The role of dopamine for the pathophysiology of schizophrenia.

Meisenzahl EM, Schmitt GJ, Scheuerecker J, Möller HJ.

Int Rev Psychiatry. 2007 Aug;19(4):337-45. Review.

PMID:
17671867
[PubMed - indexed for MEDLINE]
20.

Decreased dopamine transporter availability in male smokers -- a dual isotope SPECT study.

Yang YK, Yao WJ, Yeh TL, Lee IH, Chen PS, Lu RB, Chiu NT.

Prog Neuropsychopharmacol Biol Psychiatry. 2008 Jan 1;32(1):274-9. Epub 2007 Aug 24.

PMID:
17900774
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk